10.1182/blood-2015-08-662627 - Triplet vs doublet lenalidomide-conta...

This document has been corrected

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma

10.1182/blood-2015-08-662627

Published Online: 2016-03-03

Journal: Blood•Publisher: American Society of Hematology

Authors: Anna Marina Liberati•Annalisa Bernardini•Antonietta Pia Falcone•Antonio Ledda•Antonio Palumbo•Caterina Musolino•Concetta Conticello•Francesca Patriarca•Giovannino Ciccone•Giulia Benevolo•Giuseppe Pietrantuono•Lorenzo De Paoli•Marina Ruggeri•Mario Boccadoro•Massimo Offidani•Nicola Giuliani•Renato Zambello•Roberto Mina•Roman Hajek•Sara Bringhen•Silvia Gentili•Stefano Pulini•Tommasina Guglielmelli•Valeria Magarotto•Vittorio Montefusco•Vladimír Maisnar

This document has been corrected

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma

10.1182/blood-2015-08-662627

Published Online: 2016-03-03

Journal: Blood

NOW

2018-03-29•Correction

Magarotto V, Bringhen S, Offidani M, et al. Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma. Blood. 2016;127(9):1102-1108.

10.1182/blood-2018-02-832048

* information provided by CrossRef

2018-03-29•Correction

10.1182/blood-2018-02-832048

* information provided by CrossRef

2016-03-03•Published

2018-03-29•Correction

10.1182/blood-2018-02-832048

* information provided by CrossRef

This document has been corrected

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma

10.1182/blood-2015-08-662627

Published Online: 2016-03-03

Journal: Blood•Publisher: American Society of Hematology